Neutral
Tonix Pharmaceuticals Holding Corp. Files Form 8-K Current Report with NASDAQ Listing Details (May 1, 2026)
Tonix Pharmaceuticals Holding Corp. released preliminary Q1 2026 financial results, showing a significant increase in net loss to $40.8 million and ca...